Integra LifeSciences (NASDAQ:IART – Get Free Report) issued an update on its third quarter 2023 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.76-$0.80 for the period, compared to the consensus estimate of $0.97. The company issued revenue guidance of $386.00 million-$390.00 million, compared to the consensus revenue estimate […]
Integra LifeSciences (NASDAQ:IART – Get Free Report) updated its FY23 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $3.10-3.18 for the period, compared to the consensus estimate of $3.13. The company issued revenue guidance of $1.55-1.56 billion, compared to the consensus revenue estimate of $1.56 billion. Integra LifeSciences also updated […]
Victory Capital Management Inc. lifted its position in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 8,208.4% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,230,064 shares of the life sciences company’s stock after acquiring an additional 1,215,259 shares during the quarter. […]
Integra LifeSciences (NASDAQ:IART – Free Report) had its price objective trimmed by Piper Sandler from $55.00 to $44.00 in a research report released on Monday morning, The Fly reports. A number of other equities research analysts have also issued reports on the company. JMP Securities cut their target price on Integra LifeSciences from $75.00 to […]
Integra LifeSciences (NASDAQ:IART – Get Rating) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Tuesday. Several other equities analysts have also commented on the company. TheStreet lowered Integra LifeSciences from a “b-” rating to a “c+” rating in a research note on […]